Bank of America’s Lexicon Pharmaceuticals LXRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$30.3K Sell
32,097
-64,290
-67% -$60.8K ﹤0.01% 5944
2025
Q1
$44.3K Sell
96,387
-40,020
-29% -$18.4K ﹤0.01% 5772
2024
Q4
$101K Buy
136,407
+29,319
+27% +$21.6K ﹤0.01% 5524
2024
Q3
$168K Buy
107,088
+19,903
+23% +$31.2K ﹤0.01% 5234
2024
Q2
$146K Buy
87,185
+1,313
+2% +$2.21K ﹤0.01% 5236
2024
Q1
$206K Sell
85,872
-124,853
-59% -$300K ﹤0.01% 5042
2023
Q4
$322K Buy
210,725
+46,249
+28% +$70.8K ﹤0.01% 4897
2023
Q3
$179K Buy
164,476
+86,184
+110% +$93.9K ﹤0.01% 5096
2023
Q2
$179K Buy
78,292
+17,531
+29% +$40.1K ﹤0.01% 5078
2023
Q1
$148K Sell
60,761
-1,710
-3% -$4.16K ﹤0.01% 5289
2022
Q4
$119K Sell
62,471
-47,662
-43% -$91K ﹤0.01% 5415
2022
Q3
$264K Buy
110,133
+71,823
+187% +$172K ﹤0.01% 5047
2022
Q2
$71K Sell
38,310
-8,406
-18% -$15.6K ﹤0.01% 5870
2022
Q1
$97K Sell
46,716
-229,807
-83% -$477K ﹤0.01% 6098
2021
Q4
$1.09M Buy
276,523
+257,515
+1,355% +$1.01M ﹤0.01% 4447
2021
Q3
$91K Sell
19,008
-14,238
-43% -$68.2K ﹤0.01% 5896
2021
Q2
$153K Sell
33,246
-149,841
-82% -$690K ﹤0.01% 5489
2021
Q1
$1.08M Buy
183,087
+102,787
+128% +$604K ﹤0.01% 4195
2020
Q4
$274K Sell
80,300
-95,974
-54% -$327K ﹤0.01% 4688
2020
Q3
$254K Buy
176,274
+99,211
+129% +$143K ﹤0.01% 4559
2020
Q2
$154K Buy
77,063
+40,535
+111% +$81K ﹤0.01% 4870
2020
Q1
$71K Sell
36,528
-23,145
-39% -$45K ﹤0.01% 5117
2019
Q4
$248K Sell
59,673
-120,427
-67% -$500K ﹤0.01% 4715
2019
Q3
$542K Sell
180,100
-99,028
-35% -$298K ﹤0.01% 4311
2019
Q2
$1.76M Sell
279,128
-91,140
-25% -$573K ﹤0.01% 3547
2019
Q1
$2.06M Buy
370,268
+337,248
+1,021% +$1.88M ﹤0.01% 3420
2018
Q4
$220K Sell
33,020
-21,518
-39% -$143K ﹤0.01% 4748
2018
Q3
$581K Sell
54,538
-33,250
-38% -$354K ﹤0.01% 4186
2018
Q2
$1.05M Buy
87,788
+4,471
+5% +$53.7K ﹤0.01% 3814
2018
Q1
$714K Sell
83,317
-89,378
-52% -$766K ﹤0.01% 3972
2017
Q4
$1.71M Sell
172,695
-448,230
-72% -$4.43M ﹤0.01% 3490
2017
Q3
$7.63M Buy
620,925
+410,545
+195% +$5.05M ﹤0.01% 2407
2017
Q2
$3.46M Sell
210,380
-180,639
-46% -$2.97M ﹤0.01% 2918
2017
Q1
$5.61M Buy
391,019
+139,143
+55% +$2M ﹤0.01% 2496
2016
Q4
$3.48M Buy
251,876
+55,704
+28% +$770K ﹤0.01% 2794
2016
Q3
$3.55M Sell
196,172
-2,518
-1% -$45.5K ﹤0.01% 2673
2016
Q2
$2.85M Buy
198,690
+4,349
+2% +$62.4K ﹤0.01% 2787
2016
Q1
$2.32M Buy
194,341
+129,299
+199% +$1.55M ﹤0.01% 2858
2015
Q4
$865K Buy
65,042
+5,537
+9% +$73.6K ﹤0.01% 3620
2015
Q3
$639K Buy
59,505
+39,705
+201% +$426K ﹤0.01% 3777
2015
Q2
$159K Buy
19,800
+3,123
+19% +$25.1K ﹤0.01% 4406
2015
Q1
$111K Buy
16,677
+106
+0.6% +$706 ﹤0.01% 4318
2014
Q4
$105K Buy
16,571
+1,305
+9% +$8.27K ﹤0.01% 4510
2014
Q3
$151K Sell
15,266
-24,375
-61% -$241K ﹤0.01% 4248
2014
Q2
$447K Sell
39,641
-588
-1% -$6.63K ﹤0.01% 3601
2014
Q1
$487K Sell
40,229
-5,281
-12% -$63.9K ﹤0.01% 3549
2013
Q4
$573K Sell
45,510
-3,787
-8% -$47.7K ﹤0.01% 3532
2013
Q3
$821K Buy
49,297
+3,351
+7% +$55.8K ﹤0.01% 3141
2013
Q2
$697K Buy
+45,946
New +$697K ﹤0.01% 3454